MONTREAL INST RECH CLINIQUES has a total of 32 patent applications. Its first patent ever was published in 1981. It filed its patents most often in Australia, Canada and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are THEREXSYS LTD, UNIV NORTHEASTERN OHIO and KANKER INST NL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | Canada | 6 | |
#3 | United States | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Denmark | 1 | |
#7 | Spain | 1 | |
#8 | Greece | 1 | |
#9 | Israel | 1 | |
#10 | Portugal | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Animal care | |
#5 | Therapeutic chemical compounds | |
#6 | Unspecified technologies | |
#7 | Measuring microorganism processes | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Chretien Michel | 15 |
#2 | Seidah Nabil G | 8 |
#3 | Jolicoeur Paul | 8 |
#4 | Seidah Nabil | 7 |
#5 | Cantin Marc | 7 |
#6 | Lazure Claude | 6 |
#7 | Garcia Raul | 6 |
#8 | Thibault Gaetan | 5 |
#9 | Cromlish James A | 3 |
#10 | Drouin Jacques | 3 |
Publication | Filing date | Title |
---|---|---|
US6054571A | dft-A gene, diagnostic and therapeutic uses thereof | |
WO9850535A1 | Transgenic mice expressing hiv-1 in immune cells | |
CA2192754A1 | Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor | |
US5789564A | Development of research diagnostic and production tools for pro-hormone convertases | |
AU6608996A | Mammalian pro-hormone convertase | |
AU1742992A | Transgenic non-human animal carrying a non-infectious HIV genome | |
CA2042625A1 | Transgenic non-human animal carrying a non-infectious hiv genome | |
WO9014845A1 | Nuclear imaging uses of radio-labelled atrial natriuretic factor | |
CA1270195A | Use of anf peptides as antiglaucoma agents | |
ZA8406084B | Natriuretic factors | |
AU3123284A | Natriuretic factors | |
CA1176162A | N-terminal fragment of human pro-opiomelanocortin and process therefor |